Global Airway Management Devices Market Size, Share & Trends Analysis Report By Application, By End-use, By Product (Supraglottic Devices, Infraglottic Devices, Laryngoscopes, Resuscitators, and Others), By Regional Outlook and Forecast, 2023 - 2030
The Global Airway Management Devices Market size is expected to reach $3.5 billion by 2030, rising at a market growth of 7.2% CAGR during the forecast period.
Nasopharyngeal airways are inserted through one of the nostrils along the floor of the nasal passage. Lubrication may be applied to ease insertion. Therefore, the nasopharyngeal devices segment captured $203.2 million revenue in the market in 2022. The device is advanced gently until it reaches the nasopharynx. Unlike oropharyngeal airways, nasopharyngeal airways can be used in patients with intact gag reflexes. Nasopharyngeal airways are commonly employed in emergency medical settings, including pre-hospital care and ambulance services.
Targeted screening programs identify high-risk populations, such as individuals with a history of smoking, occupational exposure, or a family history of respiratory diseases. Identifying individuals at risk for respiratory disorders contributes to the proactive use of airway devices. As awareness grows and individuals participate in early detection efforts, the market for these devices is likely to increase.
Additionally, the prevalence of respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and sleep apnea, is on the rise globally. As per a report by World Health Organization (WHO) updated in 2023, With 3.23 million fatalities from chronic obstructive pulmonary disease (COPD) in 2019, it ranks as the third most common cause of mortality globally.
However, Pediatric patients require these devices specifically designed to accommodate their smaller anatomy. Pediatric-specific research and clinical trials for the devices are often scarce. The lack of robust evidence-based practices for pediatric airway management may result in varied approaches, creating standardization and device selection challenges. As a result, the above aspects will cause the market growth to decline.
Furthermore, the surge in COVID-19 cases, particularly severe cases leading to acute respiratory distress syndrome (ARDS), increased demand for ventilators and other respiratory support devices. These devices, including endotracheal and tracheostomy tubes, are integral to mechanical ventilation systems used in critical care settings. The urgency of the pandemic prompted accelerated research and innovation in the field of respiratory care, including airway management. There was a focus on developing new technologies, improving existing devices, and exploring alternative methods of airway management to enhance patient outcomes and reduce the burden on healthcare systems. Therefore, COVID-19 had a positive impact on the market.
By Application Analysis
Based on application, the market is fragmented into anesthesia, emergency medicine, and others. In 2022, the anesthesia segment witnessed 58.14% revenue share in the market. Endotracheal intubation is a common technique in anesthesia. It allows the anesthesiologist to control the airway, administer inhalation anesthetics, and ensure adequate oxygenation and ventilation during surgery.
By End-use Analysis
By end-use, the market is categorised into hospitals, homecare, and others. The homecare segment acquired a 28.06% revenue share in the market in 2022. Due to the increasing launches of instruments and equipment for managing airways in home settings.
By Product Analysis
On the basis of product, the market is segmented into supraglottic devices, infraglottic devices, resuscitators, laryngoscopes, and others. In 2022, the supraglottic devices segment dominated the market with the 36.14% revenue share. The growing demand for these products can be attributed to their associated benefits. The most important advantage includes easy tracheal placement, which leads to improved patient safety.
By Supraglottic Devices Analysis
Under supraglottic devices type, the market is further divided into oropharyngeal devices, nasopharyngeal devices, laryngeal airway masks, and others. In 2022, the oropharyngeal devices segment held 46.20% revenue share in the market. Oropharyngeal airways are commonly used when the patient is unconscious, under general anesthesia, or unable to maintain a clear airway independently.
By Infraglottic Devices Analysis
Under infraglottic devices type, the market is further classified into endotracheal tubes, tracheostomy tubes, and others. In 2022, the endotracheal tubes segment registered 46.57% revenue share in the market. Endotracheal intubation can be performed through the oral or nasal route. The choice depends on factors such as the patient's condition, the surgical procedure, and the healthcare provider's preferences.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region garnered a 26.15% revenue share in the market in 2022. Due to the increase in the outsourcing of the manufacturing of these devices to Asia Pacific countries, such as India and China.
Recent Strategies Deployed in the Market
- Aug-2023: ICU Medical, Inc obtained FDA clearance for Plum Duo™ Infusion Pump and LifeShield Infusion Safety Software, expanding its portfolio. The introduction complements existing infusion systems like Plum 360, Medfusion 4000, and CADD-Solis™ pumps.
- Jun-2023: Teleflex Incorporated partnered with Shenzhen Insighters Medical Technology Co., Ltd. to exclusively distribute the Insighters Video Laryngoscope system in the U.S. This collaboration enhances Teleflex's airway device portfolio, offering innovative technology and interchangeable components to address various clinical preferences.
- Jan-2022: Armstrong Medical Ltd introduced 'AquaVENT®VT' in the Middle East, minimizing caregiver time spent managing ventilator circuits, allowing them to concentrate on improving patient outcomes while ensuring consistent humidity control throughout the breathing circuit.
- Jan-2022: ICU Medical, Inc acquired Smiths Medical, enhanced its position in the medical supply chain and fostering a culture focused on customer needs, accountability, transparency, and agility.
- May-2021: Medtronic PLC has launched the SonarMed airway monitoring system in the U.S., the first FDA-cleared system of its kind, offering timely notifications and measurements to address critical events like ETT movement.
List of Key Companies Profiled
- Medtronic PLC
- Teleflex Incorporated
- Ambu A/S
- Becton, Dickinson, and Company
- Medline Industries, Inc.
- ICU Medical, Inc. (Smiths Medical)
- ConvaTec Group PLC
- Armstrong Medical Ltd
- Intersurgical Ltd
- Mercury Medical
Global Airway Management Devices Market Report Segmentation
By Application
- Anesthesia
- Emergency Medicine
- Others
By End-use
By Product
- Supraglottic Devices
- Oropharyngeal Devices
- Nasopharyngeal Devices
- Laryngeal Airway Masks
- Others
- Infraglottic Devices
- Endotracheal Tubes
- Tracheostomy Tubes
- Others
- Laryngoscopes
- Resuscitators
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA